Prothena Corporation plc(NASDAQ:PRTA) 
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing PRX002/RG7935 that is in Phase 2 clinical trial for treating Parkinson's disease and other relate...
Website: http://www.prothena.com
Founded: 2012
Full Time Employees: 51
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 11.02
H 11.37
L 10.68
C 10.86
V 416,995
10EMA 10.86
20EMA 10.86
60EMA 10.86
120EMA 10.86
250EMA 10.86